Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

7OPhase I study of CC-90011 in patients with advanced solid tumors and relapsed/refractory non-Hodgkin lymphoma (R/R NHL).

Hollebecque A, de Bono JS, Plummer R, Isambert N, Martin-Romano P, Baudin E, Mora S, Filvaroff E, Lamba M, Nikolova Z.

Ann Oncol. 2019 Feb 1;30(Supplement_1). pii: mdz029. doi: 10.1093/annonc/mdz029. No abstract available.

PMID:
30810203
2.

The novel, orally bioavailable HSP90 inhibitor NVP-HSP990 induces cell cycle arrest and apoptosis in multiple myeloma cells and acts synergistically with melphalan by increased cleavage of caspases.

Lamottke B, Kaiser M, Mieth M, Heider U, Gao Z, Nikolova Z, Jensen MR, Sterz J, von Metzler I, Sezer O.

Eur J Haematol. 2012 May;88(5):406-15. doi: 10.1111/j.1600-0609.2012.01764.x. Epub 2012 Mar 21.

PMID:
22309072
3.

Deficient recognition of emotional prosody in primary focal dystonia.

Nikolova ZT, Fellbrich A, Born J, Dengler R, Schröder C.

Eur J Neurol. 2011 Feb;18(2):329-36. doi: 10.1111/j.1468-1331.2010.03144.x.

PMID:
20666836
4.

Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma.

Reardon DA, Dresemann G, Taillibert S, Campone M, van den Bent M, Clement P, Blomquist E, Gordower L, Schultz H, Raizer J, Hau P, Easaw J, Gil M, Tonn J, Gijtenbeek A, Schlegel U, Bergstrom P, Green S, Weir A, Nikolova Z.

Br J Cancer. 2009 Dec 15;101(12):1995-2004. doi: 10.1038/sj.bjc.6605411. Epub 2009 Nov 10.

5.

Changes of emotional prosody in Parkinson's disease.

Schröder C, Nikolova ZT, Dengler R.

J Neurol Sci. 2010 Feb 15;289(1-2):32-5. doi: 10.1016/j.jns.2009.08.038. Epub 2009 Sep 4. Review.

PMID:
19732910
6.

Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomide.

Dresemann G, Weller M, Rosenthal MA, Wedding U, Wagner W, Engel E, Heinrich B, Mayer-Steinacker R, Karup-Hansen A, Fluge O, Nowak A, Mehdorn M, Schleyer E, Krex D, Olver IN, Steinbach JP, Hosius C, Sieder C, Sorenson G, Parker R, Nikolova Z.

J Neurooncol. 2010 Feb;96(3):393-402. doi: 10.1007/s11060-009-9976-3. Epub 2009 Aug 18.

PMID:
19688297
7.

Imatinib plasma levels are correlated with clinical benefit in patients with unresectable/metastatic gastrointestinal stromal tumors.

Demetri GD, Wang Y, Wehrle E, Racine A, Nikolova Z, Blanke CD, Joensuu H, von Mehren M.

J Clin Oncol. 2009 Jul 1;27(19):3141-7. doi: 10.1200/JCO.2008.20.4818. Epub 2009 May 18.

PMID:
19451435
8.

Influence of enzyme-inducing antiepileptic drugs on trough level of imatinib in glioblastoma patients.

Pursche S, Schleyer E, von Bonin M, Ehninger G, Said SM, Prondzinsky R, Illmer T, Wang Y, Hosius C, Nikolova Z, Bornhäuser M, Dresemann G.

Curr Clin Pharmacol. 2008 Sep;3(3):198-203.

9.

Phase II, open-label study evaluating the activity of imatinib in treating life-threatening malignancies known to be associated with imatinib-sensitive tyrosine kinases.

Heinrich MC, Joensuu H, Demetri GD, Corless CL, Apperley J, Fletcher JA, Soulieres D, Dirnhofer S, Harlow A, Town A, McKinley A, Supple SG, Seymour J, Di Scala L, van Oosterom A, Herrmann R, Nikolova Z, McArthur AG; Imatinib Target Exploration Consortium Study B2225.

Clin Cancer Res. 2008 May 1;14(9):2717-25. doi: 10.1158/1078-0432.CCR-07-4575.

10.

Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT.

Blanke CD, Demetri GD, von Mehren M, Heinrich MC, Eisenberg B, Fletcher JA, Corless CL, Fletcher CD, Roberts PJ, Heinz D, Wehre E, Nikolova Z, Joensuu H.

J Clin Oncol. 2008 Feb 1;26(4):620-5. doi: 10.1200/JCO.2007.13.4403.

PMID:
18235121
11.

Durable responses to imatinib in patients with PDGFRB fusion gene-positive and BCR-ABL-negative chronic myeloproliferative disorders.

David M, Cross NC, Burgstaller S, Chase A, Curtis C, Dang R, Gardembas M, Goldman JM, Grand F, Hughes G, Huguet F, Lavender L, McArthur GA, Mahon FX, Massimini G, Melo J, Rousselot P, Russell-Jones RJ, Seymour JF, Smith G, Stark A, Waghorn K, Nikolova Z, Apperley JF.

Blood. 2007 Jan 1;109(1):61-4. Epub 2006 Sep 7.

PMID:
16960151
12.

Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor).

Heinrich MC, McArthur GA, Demetri GD, Joensuu H, Bono P, Herrmann R, Hirte H, Cresta S, Koslin DB, Corless CL, Dirnhofer S, van Oosterom AT, Nikolova Z, Dimitrijevic S, Fletcher JA.

J Clin Oncol. 2006 Mar 1;24(7):1195-203.

PMID:
16505440
13.

Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225.

McArthur GA, Demetri GD, van Oosterom A, Heinrich MC, Debiec-Rychter M, Corless CL, Nikolova Z, Dimitrijevic S, Fletcher JA.

J Clin Oncol. 2005 Feb 1;23(4):866-73.

PMID:
15681532
14.

Bioequivalence, safety, and tolerability of imatinib tablets compared with capsules.

Nikolova Z, Peng B, Hubert M, Sieberling M, Keller U, Ho YY, Schran H, Capdeville R.

Cancer Chemother Pharmacol. 2004 May;53(5):433-8.

PMID:
15132131
15.

Rare KIT (CD117) expression in multiple myeloma abrogates the usefulness of imatinib mesylate treatment.

Lugli A, Went P, Khanlari B, Nikolova Z, Dirnhofer S.

Virchows Arch. 2004 Mar;444(3):264-8. Epub 2003 Dec 16.

PMID:
14677065
16.

Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta.

Apperley JF, Gardembas M, Melo JV, Russell-Jones R, Bain BJ, Baxter EJ, Chase A, Chessells JM, Colombat M, Dearden CE, Dimitrijevic S, Mahon FX, Marin D, Nikolova Z, Olavarria E, Silberman S, Schultheis B, Cross NC, Goldman JM.

N Engl J Med. 2002 Aug 15;347(7):481-7.

17.

Transplantation-induced endothelial dysfunction as studied in rat aorta allografts.

Andriambeloson E, Pally C, Hengerer B, Cannet C, Nikolova Z, Bruns C, Zerwes HG, Bigaud M.

Transplantation. 2001 Dec 27;72(12):1881-9.

PMID:
11773884
18.

FTY720: dissection of membrane receptor-operated, stereospecific effects on cell migration from receptor-independent antiproliferative and apoptotic effects.

Brinkmann V, Wilt C, Kristofic C, Nikolova Z, Hof RP, Chen S, Albert R, Cottens S.

Transplant Proc. 2001 Nov-Dec;33(7-8):3078-80. No abstract available.

PMID:
11750323
19.
20.
23.

FTY720 alters lymphocyte homing and protects allografts without inducing general immunosuppression.

Brinkmann V, Chen S, Feng L, Pinschewer D, Nikolova Z, Hof R.

Transplant Proc. 2001 Feb-Mar;33(1-2):530-1. No abstract available.

PMID:
11266942
24.
25.

Prevention of graft vessel disease by combined FTY720/cyclosporine. A treatment in a rat carotid artery transplantation model.

Nikolova Z, Hof A, Rudin M, Baumlin Y, Kraus G, Hof RP.

Transplantation. 2000 Jun 27;69(12):2525-30.

PMID:
10910272
26.

Trends in the incidence of colorectal carcinoma in three regions of south Bulgaria for the period 1985-1998.

Stanchev I, Ananoshtev N, Andonov V, Petrova V, Cholakova E, Nikolova Z, Gerov I.

Folia Med (Plovdiv). 1999;41(4):38-45.

PMID:
10786203
27.

Estimation of trends of morbidity of colorectal cancer in Plovdiv district for the period from 1985 to 1996.

Ananoshtev N, Andonov V, Tcholakova E, Petrova V, Stanchev I, Nikolova Z, Gerov I.

Folia Med (Plovdiv). 1999;41(1):112-5.

PMID:
10462938
28.

Female sex organs malignancies incidence in Plovdiv district for the period 1986-1996.

Nikolova Z, Ananoshtev N, Karnolski I.

Folia Med (Plovdiv). 1998;40(3B Suppl 3):61-5.

PMID:
10205997
29.
30.

A novel family of serine/threonine kinases participating in spermiogenesis.

Kueng P, Nikolova Z, Djonov V, Hemphill A, Rohrbach V, Boehlen D, Zuercher G, Andres AC, Ziemiecki A.

J Cell Biol. 1997 Dec 29;139(7):1851-9.

31.

Demonstration of nitric oxide synthase (NOS) in marmosets by NADPH diaphorase (NADPH-d) histochemistry and NOS immunoreactivity.

Grozdanovic Z, Nakos G, Christova T, Nikolova Z, Mayer B, Gossrau R.

Acta Histochem. 1995 Jul;97(3):321-31.

PMID:
8525791
32.

[An evaluation of the suitability of 2 methods for the rapid diagnosis of epidemic outbreaks of influenza].

Nikolova Z, Kotseva R.

Zh Mikrobiol Epidemiol Immunobiol. 1993 Nov-Dec;(6):56. Russian. No abstract available.

PMID:
8079565
33.

[The laboratory epidemiological study of the joint circulation of the influenza virus A subtypes A/H1N1/ and A/H3N2/ in Bulgaria].

Nikolova Z, Kotseva R.

Zh Mikrobiol Epidemiol Immunobiol. 1992;(11-12):30-2. Russian.

PMID:
1301658
34.

[Interepidemic influenza in Bulgaria based on laboratory research data].

Nikolova Z, Kotseva R.

Vopr Virusol. 1991 Sep-Oct;36(5):392-4. Russian.

PMID:
1803771
35.

[The use of the immunofluorescence method for the rapid diagnosis of influenza during 1968-1988 in Bulgaria].

Nikolova Z, Kotseva R.

Vopr Virusol. 1991 Mar-Apr;36(2):154-5. Russian. No abstract available.

PMID:
1882525
36.

[Study of human influenza viruses isolated in 1982 which are antigenically related to the swine flu virus].

Iamnikova SS, Shemiakin IG, Nikolova Z, Kotseva R, Aĭmar M.

Vopr Virusol. 1989 May-Jun;34(3):288-92. Russian.

PMID:
2800524
37.

[Malignant changes in the pilonidal sinus].

Mirceva D, Miskovski A, Boskovski L, Damevska L, Miskovska M, Dokić D, Daskalov O, Nikolova Z.

Acta Chir Iugosl. 1989;36 Suppl 2:778-9. Croatian. No abstract available.

PMID:
2618508
38.

[Hygienic assessment of traffic noise in the city of Kirdzhali (People's Republic of Bulgaria)].

Nikolova ZhS.

Gig Sanit. 1988 Feb;(2):71-2. Russian. No abstract available.

PMID:
3371685
39.

[Antigenic characteristics of different variants of influenza virus A(H3/N2) and their circulation in the USSR and People's Republic of Bulgaria in 1968-1980].

Zakstel'skaia LIa, Nikolova Z, Iakhno MA, Shenderovich SF, Oskerko TA.

Vopr Virusol. 1982 Nov-Dec;27(6):671-6. Russian.

PMID:
6186088
40.

[Influenza epizootic in swine due to strain A (Victoria/3/75 H3N2)].

Milev N, Pavlov N, Panaiotov P, Nikolova Z.

Vet Med Nauki. 1981;18(4):10-6. Bulgarian.

PMID:
6274080
41.

[Age profile of the antihemagglutinins and antineuraminidase antibodies in type A influenza (author's transl)].

Nikolova Z, Zakstel'skaia LIa, Kotseva R, Molibog EV.

Vopr Virusol. 1975 Sep-Oct;(5):553-6. Russian.

PMID:
54996
42.

Aspartate aminotransferase: the interaction of 6-halo-substituted analogs of pyridoxal phosphate with the apoenzyme.

Mora S, Nikolova ZV, Bocharov AL, Ivanov VI, Mamaeva OK, Stambolieva N, Florent'ev VL, Karpeiskii MYa.

Mol Biol. 1972 Jul-Aug;6(4):449-54. No abstract available.

PMID:
4659309
43.

[A comparative study of the epidemic process of influenza in the Soviet Union and the People's Republic of Bulgaria in 1969].

Zakstel'skaia LIa, Nikolova Z, Antonova IV, Kebedzhiev G, Evstigneeva NA.

Vopr Virusol. 1971 Nov-Dec;16(6):656-61. Russian. No abstract available.

PMID:
4946691
44.

[Antigenic mutability of influenza virus types A2, B and C in the People's Republic of Bulgaria during the period 1956-1967].

Nikolova Z.

Vopr Virusol. 1969 Jan-Feb;14(1):107-9. Russian. No abstract available.

PMID:
4978626
45.

[EPIDEMIOLOGICAL VERIFICATION OF THE EFFECTIVENESS OF LIVE INFLUENZA VACCINE].

IVANOV N, MANEV D, NIKOLOVA Z, KEBEDZHIEV G, ODISEEV Kh.

Vopr Virusol. 1963 May-Jun;22:291-5. Russian. No abstract available.

PMID:
14075848
46.

The use of serological investigations in studying the epidemiology of some virus infections in Bulgaria.

ANDONOV P, IVANOV N, RANGELOVA S, NIKOLOVA Z, RUSAKYEV M, CROMKOVA R.

J Hyg Epidemiol Microbiol Immunol. 1961;5:146-52. No abstract available.

PMID:
13683328
47.

[Virusological considerations on the epidemic of influenza in Sofia in 1952-55].

SHINDAROV L, IVANOV N, NIKOLOVA Z.

Suvr Med (Sofiia). 1957;8(1):3-10. Bulgarian. No abstract available.

PMID:
13455444
48.

[Method of differentiation of post-vaccinal tuberculin sensitivity from post-infection sensitivity].

TODOROV S, MARINOVA R, NIKOLOVA Z, ALEKSIEV N, PELKIN S, VASILEV V, TRILOVA S.

Suvr Med (Sofiia). 1953;4(12):9-20. Undetermined Language. No abstract available.

PMID:
13146540

Supplemental Content

Loading ...
Support Center